Previous 10 | Next 10 |
2023-11-07 14:18:02 ET Scholar Rock Holding Corporation (SRRK) Q3 2023 Earnings Conference Call November 07, 2023 08:00 AM ET Company Participants Rushmie Nofsinger - Vice President, Investor Relations & Corporate Affairs Jay Backstrom - Chief Executive Officer ...
2023-11-07 07:32:18 ET More on Scholar Rock Scholar Rock: SMA Data Readout In 2024 Makes This Worth A Look Scholar Rock: The Market Isn't Enthusiastic Despite Decent Clinical Data Jefferies upgrades Scholar Rock to buy; cites SMA, obesity drug assets Scholar ...
Completed enrollment for pivotal Phase 3 SAPPHIRE trial evaluating apitegromab; topline data expected in 4Q 2024 Expanding into cardiometabolic disorders with SRK-439, a novel investigational myostatin inhibitor Presented new data supporting proof of concept for SRK-181 in heavily...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Scholar Rock Holding Corporation (SRRK) is expected to report $-0.53 for Q3 2023
Promising anti-tumor activity in heavily pretreated clear cell renal cell carcinoma (ccRCC) patients Objective response rate (ORR) of 21.4% and disease control rate of 57% Biomarker data supports proof of mechanism across multiple tumor types Combination therapy of SRK-181...
2023-10-25 17:44:30 ET Summary The Scholar Rock Holding Corporation phase 3 SAPPHIRE study for apitegromab for the treatment of type 2 and type 2 SMA patients has completed enrollment and is expected to report results in Q4 2024. Data from the TOPAZ study showed consistent gains i...
Scholar Rock Holding Corporation (NASDAQ: SRRK) is one of today's top gainers. The company's shares are currently up 18.67% on the day to $9.09. Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious dis...
2023-10-25 10:00:16 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in F...
2023-10-24 17:37:02 ET Gainers: Vitru ( VTRU ) +15% . Scholar Rock Holding ( SRRK ) +7% . LianBio ( LIAN ) +5% . 908 Devices ( MASS ) +5% . Microsoft Corporation ( MSFT ) +4% . Losers: Forbion European A...
News, Short Squeeze, Breakout and More Instantly...
Scholar Rock Holding Corporation Company Name:
SRRK Stock Symbol:
NASDAQ Market:
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced it will host an Investor Da...
2024-05-14 07:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...